Ravi P. Nargund

8.7k citations

72 papers · 3.1k indexed · 1 hit paper · h-index 24

Endocrine and Autonomic Systems top 0.2%
Nutrition and Dietetics top 0.5%
Physiology top 2%
Endocrinology, Diabetes and Metabolism top 1%
Molecular Biology top 10%

Co-authors: Arthur A. Patchett Scott D. Feighner Lex H.T. Van der Ploeg Gerard J. Hickey Andrew Howard Roy G. Smith R G Smith Andrew D. Howard
Topics: Regulation of Appetite and Obesity (22 papers)Biochemical Analysis and Sensing Techniques (19 papers)Growth Hormone and Insulin-like Growth Factors (18 papers)
Cited by: Endocrine and Autonomic Systems Nutrition and Dietetics Endocrinology, Diabetes and Metabolism
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society The Journal of Immunology
Partner nations: United States China United Kingdom

In The Last Decade

Ravi P. Nargund

72 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Orexigenic Action of Peripheral Ghrelin Is Mediated by Neuropeptide Y and Agouti-Related Protein

2004 525 citations Easter G. Frazier, Donald J. Marsh et al. profile →

Peers

Countries citing papers authored by Ravi P. Nargund

Since Specialization

Citations

This map shows the geographic impact of Ravi P. Nargund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi P. Nargund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi P. Nargund more than expected).

Fields of papers citing papers by Ravi P. Nargund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi P. Nargund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi P. Nargund. The network helps show where Ravi P. Nargund may publish in the future.

Co-authorship network of co-authors of Ravi P. Nargund

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi P. Nargund. A scholar is included among the top collaborators of Ravi P. Nargund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi P. Nargund. Ravi P. Nargund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B 2020 ·Bioorganic & Medicinal Chemistry Letters ·Dong Xiao,Xing Dai,Hong Liu,Shuwen He,Zhicai Shi,Steven W. Ludmerer,Fangbiao Li,Ravi P. Nargund,Anandan Palani	4
2	Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts 2018 ·Diabetes ·Mary Courtney Moore,David E. Kelley,Raul C. Camacho,Peter Zafian,Ye Tian,Songnian Lin,Niels C. Kaarsholm,Ravi P. Nargund,(unknown),Margaret van Heek,Stephen F. Previs,Christopher R. Moyes,Marta S. Smith,Ben Farmer,P. E. V. Williams,Alan D. Cherrington	15
3	The synthesis of 2,3,6-trisubstituted 1-oxo-1,2-dihydroisoquinolines as potent CRTh2 antagonists 2017 ·Bioorganic & Medicinal Chemistry Letters ·Xianhai Huang,(unknown),Wei Zhou,Robert Aslanian,Ravi P. Nargund,Alexei V. Buevich,Li‐Kang Zhang,Hongchen Qiu,Xiaoxin Yang,Charles G. Garlisi,Craig C. Correll,Anandan Palani	7
4	Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes 2016 ·Bioorganic & Medicinal Chemistry Letters ·Jonathan E. Wilson,Ravi Kurukulasuriya,Christopher J. Sinz,(unknown),(unknown),Dann L. Parker,Edward C. Sherer,(unknown),Karen H. Dingley,Xiaofang Li,(unknown),Sharon Tong,(unknown),Anka G Ehrhardt,Birgit T. Priest,Kevin S. Ratliff,Feroze Ujjainwalla,Ravi P. Nargund,William K. Hagmann,Scott D. Edmondson	12
5	Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists 2015 ·Bioorganic & Medicinal Chemistry Letters ·Zhong Lai,Shuwen He,Edward C. Sherer,Zhicai Wu,(unknown),Richard Ball,Qingmei Hong,David Yang,(unknown),Derun Li,(unknown),Gary G. Chicchi,(unknown),Kwei‐Lan Tsao,Yunping Zhou,Andrew D. Howard,Ravi P. Nargund,William K. Hagmann	2
6	Lack of Protection with a Novel, Selective Melanocortin Receptor Subtype-4 Agonist RY767 in a Rat Transient Middle Cerebral Artery Occlusion Stroke Model 2008 ·Pharmacology ·Christopher P. Regan,(unknown),Alison M. Strack,David H. Weinberg,Ravi P. Nargund,Zhixiong Ye,(unknown),Tung M. Fong,Ian J. Reynolds,Joseph J. Lynch	9
7	Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators 2008 ·Bioorganic & Medicinal Chemistry Letters ·Liangqin Guo,Zhixiong Ye,Feroze Ujjainwalla,Heather L. Sings,Iyassu K. Sebhat,John D. Huber,David H. Weinberg,Rui Tang,Tanya MacNeil,Constantin Tamvakopoulos,(unknown),Euan MacIntyre,Lex H.T. Van der Ploeg,Mark T. Goulet,Matthew J. Wyvratt,Ravi P. Nargund	8
8	Melanocortin subtype 4 receptor agonists: Structure–activity relationships about the 4-alkyl piperidine core 2006 ·Bioorganic & Medicinal Chemistry Letters ·Iyassu K. Sebhat,Yingjie Lai,Khaled Barakat,Zhixiong Ye,Rui Tang,Rubana N. Kalyani,Aurawan Vongs,Tanya MacNeil,David H. Weinberg,M. Angeles Cabello,Marta Maroto,Ana Teran,Tung M. Fong,Lex H.T. Van der Ploeg,Arthur A. Patchett,Ravi P. Nargund	2
9	Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands 2005 ·Bioorganic & Medicinal Chemistry Letters ·Raman K. Bakshi,Qingmei Hong,Rui Tang,Rubana N. Kalyani,Tanya MacNeil,David H. Weinberg,Lex H.T. Van der Ploeg,Arthur A. Patchett,Ravi P. Nargund	12
10	Structure–activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in rat 2005 ·Peptides ·Zhixiong Ye,Tanya MacNeil,David H. Weinberg,Rubana N. Kalyani,Rui Tang,Alison M. Strack,Beth Murphy,Ralph T. Mosley,D. Euan MacIntyre,Lex H.T. Van der Ploeg,Arthur A. Patchett,Matthew J. Wyvratt,Ravi P. Nargund	8
11	Activation of melanocortin MC4 receptors increases erectile activity in rats ex copula 2002 ·European Journal of Pharmacology ·William J. Martin,Erin McGowan,Doreen E. Cashen,Liza Gantert,Jennifer E. Drisko,Gary J. Hom,Ravi P. Nargund,Iyassu K. Sebhat,Andrew D. Howard,Lex H.T. Van der Ploeg,D. Euan MacIntyre	64
12	The role of melanocortins in body weight regulation: opportunities for the treatment of obesity 2002 ·European Journal of Pharmacology ·Douglas J. MacNeil,Andrew D. Howard,Xiao-Ming Guan,Tung M. Fong,Ravi P. Nargund,Maria A. Bednarek,Mark T. Goulet,David H. Weinberg,Alison M. Strack,Donald J. Marsh,Howard Y. Chen,Chun-Pyn Shen,Airu S. Chen,Charles Rosenblum,Tanya MacNeil,Michael R. Tota,Euan MacIntyre,Lex H.T. Van der Ploeg	54
13	Design and biological profile for selective agonists for the melanocortin subtype-4 receptor 2001 ·Ravi P. Nargund,Iyassu K. Sebhat,(unknown),Khaled Barakat,David H. Weinberg,Tanya MacNeil,Rubana N. Kalyani,William J. Martin,Doreen E. Cashen,(unknown),Jennifer E. Drisko,Ralph Mosley,Tung M. Fong,Ralph A. Stearns,Randy R. Miller,(unknown),Lawrence F. Colwell	1
14	Immune Enhancing Effect of a Growth Hormone Secretagogue 2001 ·The Journal of Immunology ·Gloria C. Koo,Christopher Huang,Ramon E. Camacho,(unknown),(unknown),(unknown),Klaus D. Schleim,Tsuei-Ju Wu,Kang Cheng,Ravi P. Nargund,(unknown)	86
15	Orphan G-protein-coupled receptors and natural ligand discovery 2001 ·Trends in Pharmacological Sciences ·Andrew Howard,George McAllister,Scott D. Feighner,Qingyun Liu,Ravi P. Nargund,Lex H.T. Van der Ploeg,Arthur A. Patchett	219
16	Spiro(indoline-3,4′-piperidine) growth hormone secretagogues as ghrelin mimetics 2001 ·Bioorganic & Medicinal Chemistry Letters ·Brenda L. Palucki,Scott D. Feighner,(unknown),Karen K. McKee,Donna L. Hreniuk,Carina P. Tan,(unknown),(unknown),Arthur A. Patchett,Ravi P. Nargund	28
17	Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues 2000 ·Bioorganic & Medicinal Chemistry Letters ·Zhixiong Ye,(unknown),Raman K. Bakshi,Meng‐Hsin Chen,Susan P. Rohrer,Scott D. Feighner,Sheng‐Shung Pong,Andrew D. Howard,Allan D. Blake,Elizabeth T. Birzin,Louis Locco,Rupa M. Parmar,Wanda Chan,James M. Schaeffer,Roy G. Smith,Arthur A. Patchett,Ravi P. Nargund	19
18	Tripeptide growth hormone secretagogues 1998 ·Bioorganic & Medicinal Chemistry Letters ·Lihu Yang,(unknown),Yanping Pan,Ravi P. Nargund,Khaled Barakat,Kristine Prendergast,(unknown),Wanda Chan,R G Smith,Arthur A. Patchett	8
19	Synthesis and biological activities of phenyl piperazine- based peptidomimetic growth hormone secretagogues 1998 ·Bioorganic & Medicinal Chemistry Letters ·Khaled J. Barakat,(unknown),Wanda Chan,(unknown),Thomas M. Jacks,Klaus D. Schleim,(unknown),Gerard J. Hickey,R G Smith,Arthur A. Patchett,Ravi P. Nargund	15
20	Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles 1997 ·Journal of Endocrinology ·Gerard J. Hickey,Thomas M. Jacks,Klaus D. Schleim,Easter G. Frazier,(unknown),David Krupa,William P. Feeney,Ravi P. Nargund,Arthur A. Patchett,R G Smith	38

About Ravi P. Nargund

Ravi P. Nargund is a scholar working on Endocrine and Autonomic Systems, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics, having authored 72 papers that have together received 3.1k indexed citations. Recurring topics across this work include Regulation of Appetite and Obesity (22 papers), Biochemical Analysis and Sensing Techniques (19 papers) and Growth Hormone and Insulin-like Growth Factors (18 papers). The work is most often cited by research in Endocrine and Autonomic Systems (1.9k citations), Nutrition and Dietetics (1.2k citations) and Endocrinology, Diabetes and Metabolism (875 citations). Ravi P. Nargund has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Arthur A. Patchett, Scott D. Feighner, Lex H.T. Van der Ploeg, Gerard J. Hickey, Andrew Howard, Roy G. Smith, R G Smith, Andrew D. Howard, Kang Cheng and Matthew J. Wyvratt. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact